Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 29,900 | 63,611 | 69,414 | 57,971 | 66,893 |
| Cost of Goods | 3,066 | 15,824 | 16,410 | 8,398 | 22,526 |
| Gross Profit | 26,834 | 47,787 | 53,005 | 49,574 | 44,367 |
| Operating Expenses | 313,982 | 136,610 | 108,954 | 105,084 | 119,495 |
| Operating Income | -287,082 | -87,999 | -55,540 | -55,113 | -74,602 |
| Interest Expense | 61,705 | 43,862 | 48,584 | 30,882 | 30,336 |
| Other Income | 9,371 | 183,250 | -25,554 | 5,341 | 57,245 |
| Pre-tax Income | -339,417 | 51,389 | -129,678 | -80,654 | -47,693 |
| Income Tax | -1,718 | -1,783 | 496 | N/A | N/A |
| Net Income Continuous | -337,699 | 53,171 | -130,174 | -80,654 | -47,693 |
| Net Income Discontinuous | -4,257 | N/A | N/A | N/A | N/A |
| Net Income | $-341,955 | $53,171 | $-130,174 | $-80,654 | $-47,693 |
| EPS Basic Total Ops | -2.27 | 0.39 | -0.95 | -0.59 | -0.35 |
| EPS Basic Continuous Ops | -2.24 | 0.40 | -0.95 | -0.59 | -0.35 |
| EPS Basic Discontinuous Ops | -0.03 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.27 | 0.39 | -0.95 | -0.59 | -0.35 |
| EPS Diluted Continuous Ops | -2.24 | 0.40 | -0.95 | -0.59 | -0.35 |
| EPS Diluted Discontinuous Ops | -0.03 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.24 | 0.33 | -0.95 | -0.59 | -0.35 |
| EBITDA(a) | $-285,950 | $-85,822 | $-52,576 | $-51,818 | $-71,637 |